Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Novel Protein Masking DAMPs by BioSeedin for Neuropathic Pain (Neuralgia): Likelihood of Approval
Novel Protein Masking DAMPs is under clinical development by BioSeedin and currently in Phase I for Neuropathic Pain (Neuralgia). According...
Data Insights
Novel Protein Masking DAMPs by BioSeedin for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Novel Protein Masking DAMPs is under clinical development by BioSeedin and currently in Phase I for Keratoconjunctivitis Sicca (Dry Eye)....